# Vulval Intraepithelial Neoplasia: A 15-Year Review of Treatment Outcomes in a UK Centre

**Authors:** Mark A McGowan, Krishnayan Haldar, Pubudu Pathiraja, Jane Sterling, Peter Baldwin

PMC · DOI: 10.7759/cureus.95074 · Cureus · 2025-10-21

## TL;DR

This study reviews 15 years of VIN treatment outcomes in the UK, finding that unifocal VIN with clear-margin excision has the lowest recurrence risk, while multifocal VIN requires close monitoring.

## Contribution

The study provides new insights into VIN recurrence patterns based on treatment modality and disease extent in a long-term cohort.

## Key findings

- Unifocal VIN with clear-margin excision had the longest time to recurrence.
- Multifocal VIN showed high recurrence risk across all treatment types.
- Positive surgical margins were associated with earlier recurrence in unifocal VIN.

## Abstract

Background

Vulvar intraepithelial neoplasia (VIN) is a premalignant condition with a high risk of recurrence. Understanding recurrence patterns may help guide treatment planning and follow-up, particularly when comparing unifocal and multifocal disease.

Methods

We conducted a 15-year retrospective cohort study of patients treated for VIN at Cambridge University Hospitals, a tertiary referral center in Cambridge, England, from 2008 to 2022. Patients received local excision (clear or positive margins), CO₂ laser ablation, or medical therapy (imiquimod/cidofovir) and were stratified into unifocal or multifocal subgroups. Demographic and clinical characteristics were analyzed, with recurrence rates and time to recurrence compared across groups.

Results

A total of 108 patients were included: 26 treated with local excision with clear margins, 44 with excision with positive margins, 25 with laser, and 13 with medical therapy. The median age was 51 years (95% CI 50-55). In unifocal disease, time to recurrence differed significantly by treatment modality (p = 0.04), with the longest median interval in patients with clear-margin excision. In multifocal disease, recurrence risk remained high across all treatment groups without significant differences in time to recurrence (p = 0.21).

Conclusions

Unifocal VIN treated with excision and negative margins was associated with the lowest recurrence risk, supporting the possibility of reduced follow-up intensity in selected cases. By contrast, positive margins and multifocal disease were linked with earlier and more frequent recurrence, underscoring the importance of close, long-term surveillance. These findings may inform follow-up strategies, although further research is needed.

## Linked entities

- **Chemicals:** imiquimod (PubChem CID 57469), cidofovir (PubChem CID 60613)
- **Diseases:** vulvar intraepithelial neoplasia (MONDO:0005198), VIN (MONDO:0005198)

## Full-text entities

- **Diseases:** Intraepithelial Neoplasia (MESH:D002578)
- **Chemicals:** CO2 (MESH:D002245), imiquimod (MESH:D000077271), cidofovir (MESH:D000077404)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12633784/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12633784/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12633784/full.md

---
Source: https://tomesphere.com/paper/PMC12633784